Cabbacis Inc. Stock Analysis CABI

Cabbacis, Inc. operates as a tobacco product manufacturing and plant biotechnology company. The company is headquartered in Niagara Falls, New York and currently employs 3 full-time employees. The company went IPO on 2024-11-01. The Company, through its wholly owned subsidiary Cabbacis LLC, operates as a federally licensed, tobacco product manufacturer and plant biotechnology company developing and commercializing consumer acceptable Modified Risk Tobacco Products (MRTPs). The company has not commercialized its products which it is developing under the iBlend brand name, and its primary focus is the development of cigarettes with blends of reduced-nicotine tobacco containing about 95 percent less nicotine than that of United States brands and very-low THC cannabis, (commonly known as hemp), which is not intoxicating since it contains less than 0.3 percent THC. The firm is also developing pods for oral electronic vaporizers.